As primary studies indicate, tetrahydroxycurcumin alone shows anti‐cancerous effects with the possible inhibition of colon cancer cell expression through the nuclear factor‐kappa B (NF‐κB) pathway. This evidence concerns the gene NFKB1 and colonic neoplasm.